Enanta’s Phase II Challenge Data Position A Second Potential RSV Therapy

 
• By Joseph Haas
  
RSV illus
Enanta is advancing two antivirals to treat RSV infections • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D